Phibro Animal Health traded at $19.59 this Friday July 1st, increasing $0.46 or 2.40 percent since the previous trading session. Looking back, over the last four weeks, Phibro Animal Health gained 0.82 percent. Over the last 12 months, its price fell by 33.68 percent. Looking ahead, we forecast Phibro Animal Health to be priced at 19.06 by the end of this quarter and at 17.55 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Aurora Cannabis Inc 1.69 -0.01 -0.59% -84.21%
Align Technology 247.34 10.67 4.51% -60.37%
ANI Pharmaceuticals 31.54 1.87 6.29% -10.00%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Corcept Therapeutics 25.44 1.66 6.98% 14.03%
Depomed 3.15 0.20 6.78% 115.75%
Endo International 0.57 0.10 22.42% -86.74%
Knight Therapeutics Inc 5.40 0.06 1.12% 2.86%
Henry Schein 77.11 0.37 0.48% 1.50%
Idexx Laboratories 358.44 7.71 2.20% -44.70%
Jazz Pharmaceuticals 158.58 2.57 1.65% -12.63%
Lannett 0.56 -0.02 -3.46% -87.85%
Eli Lilly 324.71 0.48 0.15% 38.79%
Merck & Co 92.42 1.25 1.37% 17.58%
Nektar Therapeutics 3.75 -0.05 -1.32% -78.08%
Phibro Animal Health 19.59 0.46 2.40% -33.68%
Prestige Brands 59.58 0.78 1.33% 14.14%
Pacira 57.85 -0.45 -0.77% -2.41%
Patterson Companies 30.59 0.29 0.96% 0.66%
Supernus Pharmaceuticals 29.35 0.43 1.49% -3.36%
Teva Pharmaceutical Industries 7.89 0.37 4.92% -19.74%
Canopy Growth Corp 3.63 -0.03 -0.82% -87.38%
Zoetis 174.21 2.32 1.35% -9.60%

Indexes Price Day Year
USND 11128 99.11 0.90% -23.99%
US2000 1728 19.77 1.16% -25.07%

Phibro Animal Health
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company develops, manufactures and markets a range of products for food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company sells animal health and mineral nutrition products either directly to integrated poultry, swine and cattle producers or through commercial animal feed manufacturers, wholesalers and distributors. Its Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company's MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.